Clinical Trial Update: Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells [NA]

View source ↗

Summary

A clinical trial evaluating non-invasive prenatal diagnosis of Down syndrome by analyzing circulating fetal cells has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Trisomy 21 | NA | Status: COMPLETED